Bio Path reported $-3546000 in Operating Profit for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Profit Change
Baxter International BAX:US USD 191M 2.99B
Bio Path BPTH:US USD -3546000 536K
Karyopharm Therapeutics KPTI:US USD -33869000 3.03M
Seattle Genetics SGEN:US USD -154004000 38.8M
Spectrum Pharmaceuticals SPPI:US USD -11645000 9.95M